Induction of Lfa-1-mediated homotypic adhesions in promonocytic U-937 cells occurs independently of cell differentiation by Cabañas, C. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/27185
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Biochimica et Biophysica Acta, 1092 (1991) 165-168 
© 1991 Elsevier Science Publishers B.V. 0l67-4889/91/$03.50 
AD O N IS  016748899100137Z
165
BBAMCR 12912
Induction of LFA-1-mediated homotypic adhesions 
in promonocytic U-937 cells occurs independently 
of cell differentiation
Carlos Cabañas \  Pedro Lastres \  Teresa Bellón \  Patricio Aller 1, Carl G. Figdor 2, 
Angel Corbi 3 and Carmelo Bernabeu 1
mJ 2 i .Centro de Investigaciones Biológicas, C,S,I, C., Madrid (Spain), The Netherlands Cancer Institute, Amsterdam (The Netherlands)
and 3 Servicio de Inmunología, Hospital de La Princesa-UAM, Madrid (Spain)
(Received 11 September 1990)
Key words: LFA-1; Homotypic adhesion; Monocyte differentiation
The differentiation of monocytes into macrophages occurs along with a marked increase in LFA-1-dependent 
intercellular adhesions. Similarly, the phorbol ester-induced differentiation of U-937 promonocytic cells into macro­
phage-like cells is morphologically characterized by an important increase in LFA-1 /ICAM-1-dependent intercellular 
homotypic adhesions. Since an important functional role in activation of human T cells has been demonstrated for 
LFA-l-dependent adherence, we have analyzed whether the induction of LFA-l-dependent intercellular adhesion of 
human monocytic cells is necessarily accompanied by differentiation of these cells. We found that treatment of the 
promonocytic U-937 cells with the anti-LFA-1 mAb NKI-L16 induces formation of intercellular clusters, but does not 
induce cell differentiation as determined by several differentiation markers. These markers include the arrest of cell 
proliferation, production of reactive oxygen species, changes in the cell surface expression of differentiation-associated 
antigens such as the transferrin receptor, CDllb and C D llc and changes in the levels of several specific gene 
transcripts such as CD 18 antigen, c-myc, ornithine decarboxylase and vimentin. These findings suggest that LFA-l-de­
pendent adhesion and differentiation of monocytic cells are independent processes.
Introduction
In mononuclear phagocytes, the regulation of cell-cell 
adhesion is an important aspect of their function and 
development. Thus, monocytes initiate diapedesis by 
adherence to the endothelium, extravasate and maturate 
into tissue macrophages. In addition, upon antigen chal­
lenge macrophages infiltrate into the site of inflamma­
tion and display homotypic (macrophage-macrophage) 
and heterotypic (macrophage-T cell) interactions. These 
cellular associations can lead to granuloma formation in 
certain diseases (lepromatous leprosy, tuberculosis, 
sarcoidosis, etc.) [1]. When monocytes are exposed in 
vitro to immunologic or inflammatory stimuli such as 
interferon gamma, LPS or TNF, an induction of homo-
typic adhesions occurs concomitantly with activation 
and differentiation of these cells [2-4]. Similarly, phor­
bol esters induce cellular differentiation as well as an 
increase in intercellular adhesions, as evidenced by cell 
cluster formation, in the human promonocytic U-937 
cells and in the myelomonocytic cell line HL-60 [5-10]. 
This adhesion of monocytic cells is mediated by the 
LFA-1 and ICAM-1 molecules [10,11]. Since binding of 
ligand to LFA-1 is required for T cell function [12] and 
the existence of regulatory signals conveyed by LFA-1 
has been suggested for T lymphocytes [13,14], we have 
analyzed in this report the possible occurrence of cell 
differentiation in the human promonocytic U-937 cells 
when these cells are induced to agregate via LFA- 
1/ICAM -l by a mAb specific for LFA-1.
Abbreviations: DCFH-DA, 2 ' ,7 '-dichlorofluorescein diacetate; 
OrnDC, ornithine decarboxylase.
Correspondence: Carmelo Bernabeu, Centro de Investigaciones, 
Biológicas, CSIC Velazquez 144, 28006 Madrid, Spain.
Materials and Methods
Antibodies
The mAb NKI-L16 (anti-LFA-1 a. or C D lla) in­
duces LFA-1/ICAM-1 mediated homotypic interac­
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tions [15]. The mAh FG1/6 (anti-transferrin receptor or 
CD71) [16], Bearl (anti-CDllb) [17] and H C l/1  (anti- 
CDllc) [18] were generated in our laboratories. Anti­
bodies were of the IgGl (FG1/6, H C l/1  and Bearl) 
and IgG2a (NKI-L16) subclasses. Antibody NKI-L16 
was added to cell cultures as 1:1000 dilution of ascites 
fluid.
Cells
The promonocytic U-937 and the myelomonocytic 
HL-60 cells were cultured in RPMI 1640 medium supp­
lemented with 10% heat-inactivated fetal calf serum, 2 
mM glutamine, penicillin (100 U/ml) and streptomycin 
(100 ng/ml) (Flow Laboratories, Rockwell, MD) in a 
5% C02 atmosphere at 37°C. When necessary, cells 
were incubated with either NKI-L16 mAb (1:1000 dilu­
tion of ascites fluid) or 10 ng/m l of PMA for 24-48 h 
to induce intercellular cluster formation or cell differ­
entiation.
Markers of monocytic differentiation
Cellular proliferation was measured as previously 
described [19], Flow cytometry analysis was performed 
with an EPICS-CS flow cy tome ter (Coulter Cientifica, 
Mostoles, Spain) using logarithmic amplifiers. For anti­
gen expression analysis, cells were incubated with the 
corresponding mAb for 30 min at 4°C. After two washes 
with NaCl/Pj (140 mM NaCl, 3 mM KClt 8 mM 
N a2HP04 and 8 mM KH2P04, pH 7.4), FITC-labeled 
rabbit anti-mouse IgGl (Nordic Immunology, Tilburg, 
Denmark) were added and incubation followed by an 
additional period of 30 min at 4°C. Finally, cells were 
washed twice with NaCl/Pj and their fluorescence 
estimated.
Determination of generation of hydrogen peroxide 
was carried out as reported by Bass et al. [20]. Briefly, 
U-937 cells were loaded with the nonfluorescent com­
pound 2',7 '-dichlorofluorescein diacetate (DCFH-DA), 
which is deacetylated by cellular esterases into DCFH. 
Then, the oxidation of DCFH by the stimulus-induced 
generation of hydrogen peroxide results in the fluo­
rescent compound DCF which is detected by flow cy­
tometry.
RNA blot analyses were performed basically as de­
scribed [19]. The probes used were: the 1.5 kb Cla I- 
EcoRl fragment of pMC413rC plasmid [21], which con­
tains the 3rd exon of human c-myc\ the 1.1 kb human 
vimentin-specific Xhol fragment of L3A7A plasmid 
[22]; the 1.5 kb OrnDC-specific Xhol fragment of OD- 
821 plasmid (a generous gift from Dr. L. Kaczmareck, 
Varsow, Poland); and the 1 kb £o?RI fragment from 
the cDNA of the human CD 18 antigen [23].
Results
The addition of the anti-LFA-1 mAb NKI-L16 to 
U-937 cultures results in an important induction of 
intercellular homotypic adhesions evidenced by forma­
tion of large cell clusters which remain in suspension in 
the culture medium (Fig. 1). These aggregates are in­
duced as soon as 2 h after the addition of the mAb and 
the cells remain clustered for up to 3 days. A similar 
effect on cluster formation is induced by treatment of 
U-937 cells with the phorbol ester PMA. However, this 
PMA-induced aggregation of U-937 cells is somehow 
different from that induced by NKI-L16, since it is not 
observable before 15-20 h of treatment with PMA and 
is accompanied by an important increase in cellular 
adhesiveness to the plastic substrate. Both, NKI-L16 
and PMA induced cell aggregates are LFA-1 /ICAM-1- 
mediated, since mAb to either of these ligands are able 
to inhibit cluster formation.
To address the question of whether this LFA-l-medi- 
ated aggregation of U-937 cells induced by the mAb 
NKI-L16 is also accompanied by induction of cell dif­
ferentiation, as is the case for PMA, we have analyzed 
the changes in several myeloid differentiation markers. 
Proliferation of U-937 cells completely ceases upon 
induction of differentiation into macrophage-like cells 
with PMA (Table I). On the contrary, the addition of 
the mAb NKI-L16 had no effect on U-937 prolifera­
tion.
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Fig. 1 , Photomicrographs of LFA-l-mediated homotypic adhesions induced by the mAb NKI-L16. U937 cells were incubated in the absence
(control) or in the presence of either the mAb NKI-L16 (anti-LFA-1) or PMA as described in Materials and Methods.
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TABLE I
Effect of homotypic adhesions induced by the NKI-L16 mAh on the 
proliferation of U937 cells
U937 cells were cultured in the absence or in the presence of either 
PMA or NKI-LJ6 mAb. The [3H]-thymidine uptake was measured as 
described in Materials and Methods. The mAb 8F3 (anti~CD13) was 
included as a control.
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Treatment [3H]Thymidine uptake 
(cpm)
None 72682
PMA 1102
NKI-L16 64453
8F3 65 571
Fig. 2 shows the changes in the cell surface expres­
sion of CDllb, C D llc and CD71 antigens during the 
PMA-induced differentiation of U-937 cells. An im­
portant increase in C D llb and C D llc expression and 
the loss of CD71 characterize the differentiation of 
U-937 into macrophage-like cells [18]. However, the 
induction of intercellular homotypic adhesion induced 
by NKI-L16 is not accompanied by any of the afore­
mentioned antigenic changes.
Also, the differentiation of U-937 cells induced with 
PMA is characterized by an important decrease in the 
levels of c-myc and OrnDC as well as the marked 
increase of the levels of CD18 and vimentin transcripts 
[19,24]. In contrast, the treatment of U-937 cells with 
NKI-L16 has no effect on the levels of any of these 
gene transcripts (Fig. 3).
Finally, the differentiation of U-937 into macro­
phage-like cells is functionally characterized by the 
acquisition of capacity to generate reactive oxygen de­
rivatives. Fig. 4 shows that PMA-differentiated U-937 
cells but not NKI-L16-treated cells are able to generate
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Fig. 2. Analysis of the expression of C D llb , C D llc  and CD71 
antigens on U937 cells treated with the mAb NKI-L16. Cells treated 
in the absence or in the presence of either PMA or NKI-L16 mAb 
were analyzed by flow cytometry using HC1/1 (anti-CDllc), Bear 1 
(anti-CDllb) or FG 1/6  (anti-CD71) mAb. Numbers at the upper
right corner indicate the percentage of positive cells.
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Fig. 3. Effect of NKI-L16 induced homotypic adhesions on the levels 
of c-myc, OrnDC, vimentin and CD18 transcripts. Total cytoplasmic 
RNA was extracted from untreated cells (0 h) or cells treated with 
either NKI-L16 mAb (24 h) or PMA (24 h). RNA blots (15 /ig per 
lane) were prepared and hybridized with c-myc> ornithine decarboxy­
lase (OrnDC), CD18 and vimentin probes.
hydrogen peroxide upon stimulation with high doses of
PMA.
Taken together, these results suggest that LFA-1 -de­
pendent homotypic adhesions are not sufficient to in­
duce monocytic differentiation of U937 cells.
Discussion
Interactions of monocytes with endothelial cells and 
with a variety of cell types and matrices occur concom- 
itanly with their differentiation into tissue macrophages. 
The importance in this process of the CDll/CD18-de- 
pendent interactions is evidenced in CD18 immunodefi- 
cient patients by the paucity of phagocytes at the site of 
inflammation [25]. Using the human promonocytic cell 
line U937 as an experimental model of differentiation, 
we show that extensive LFA-l/ICAM-l-dependent in­
teractions can occur in the absence of monocytic differ­
entiation. This conclusion is supported by the findings 
that (a) PMA is able to differentiate U937 cells into 
macrophage-like cells in the absence of LFA-1 /ICAM- 
1-dependent cellular interactions [19]; and (b) in CD18 
deficient patients, LFA-1 adhesion independent func­
tions of phagocytes are all normal, including shape 
changes, binding of chemotactic compounds (FMLP) 
and oxygen radical generation to soluble stimuli [26].
Our results using monocytic cells do not support the 
existence of LFA-1-mediated transductive signals as
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Fig. 4. Effect of NKI-L16 induced homotypic adhesions on the 
generation of reactive oxygen species. U-937 cells were incubated in 
the absence or in the presence of either PM A or the mAb NKI-L16 
for 48 h. Then, cells were loaded with DCFH-DA followed by 
stimulation with PM A and the fluorescence of the DCF generated 
was estimated by flow cytometry using logarithmic amplifiers. Cells 
treated with hydrogen peroxide (500 /aM) were included as a positive 
control. Numbers at the upper right corner indicate the mean fluores­
cence intensity.
reported for T cells [13,14]. On the contrary, we think 
that the NKI-L16 mAb affects the conformation of 
LFA-1, thereby increasing the affinity for ICAM-1 
without the need for signal transduction [27], On the 
other hand, we can not exclude the requirement for 
other types of cell-cell and cell-matrix interactions 
during the monocytic differentiation process. In this 
sense, the monocytic antigen VLA-4 is able to interact 
with the endothelial molecule VCAM-1 [28]. Further­
more, the endothelial antigens CD62 and ELAM-1 and 
the homing receptor MEL-14 present in monocytes, are 
able to interact with the corresponding counterstruc­
tures (so far unknown) to allow monocyte-endothelial 
cell adhesions [29]. The possible implication of these 
molecules in the differentiation process needs to be 
elucidated.
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